Muscle satellite cells are impaired in type 2 diabetic mice by elevated extracellular adenosine

作者：Han, Lifang; Wang, Gang; Zhou, Shaopu; Situ, Chenghao; He, Zhiming; Li, Yuying; Qiu, Yudan; Huang, Yu; Xu, Aimin; Ong, Michael Tim Yun; Wang, Huating; Zhang, Jianfa; Wu, Zhenguo^*

来源：Cell Reports, 2022, 39(9): 110884.

DOI：10.1016/j.celrep.2022.110884

• SKELETAL-MUSCLE
• STEM-CELLS
• KINASE INHIBITOR
• PLASMA 5'-AMP
• FATTY-ACIDS
• IN-VITRO
• QUIESCENCE
• RECEPTOR
• INSULIN
• INFLAMMATION

Muscle regeneration is known to be defective under diabetic conditions. However, the underlying mechanisms remain less clear. Adult quiescent muscle satellite cells (MuSCs) from leptin-receptor-deficient (i.e., db/db) diabetic mice are defective in early activation in vivo, but not in culture, suggesting the involvement of pathogenic niche factors. Elevated extracellular adenosine (eAdo) and AMP (eAMP) are detected under diabetic conditions. eAdo and eAMP potently inhibit cell cycle re-entry of quiescent MuSCs and injury induced muscle regeneration. Mechanistically, eAdo and eAMP engage the equilibrative Ado transporters (ENTs)-Ado kinase (ADK)-AMPK signaling axis in MuSCs to inhibit the mTORC1-dependent cell growth checkpoint. eAdo and eAMP also inhibit early activation of quiescent fibroadipogenic progenitors and human MuSCs by the same mechanism. Treatment of db/db diabetic mice with an ADK inhibitor partially rescues the activation defects of MuSCs in vivo. Thus, both ADK and ENTs represent potential therapeutic targets for restoring the regenerative functions of tissue stem cells in patients with diabetes.

• 单位
  南京理工大学